Speakers

CONFIRMED SPEAKERS INCLUDE*:

• Nancy Berg, ISPOR CEO, ISPOR, Lawrenceville, NJ, USA
• J. Jaime Caro, MDCM, Evidera, Boston, MA, USA
• Rick Chapman, PhD, MS, ICER, Boston, MA, USA
• Patricia Danzon, PhD, University of Pennsylvania, Philadelphia, PA, USA
• Nancy Devlin, PhD, Office of Health Economics, London, UK
• Robert DuBois, MD, National Pharmaceutical Council, Washington, DC, USA
• Lou Garrison, PhD, University of Washington, Seattle, WA, USA
• Patrick Gleason, PharmD, Prime Therapeutics, Eagan, MN, USA
• Susan Griffin, PhD, University of York, York, UK
• Jeroen Jansen, PhD, The Innovation and Value Initiative, Los Angeles, CA, USA
• Reed Johnson, PhD, Duke University, Durham, NC, USA
• Bryan Luce, PhD, Evidera (for the PhRMA Foundation), Seattle, WA, USA
• Mark McClellan, MD, PhD, Duke-Margolis Health Policy Center, Washington, DC, USA
• Newell McElwee, PharmD, MSPH, Boehringer-Ingelheim, CT, USA
• John M. O'Brien, PharmD, MPH US Department of Health & Human Services, Washington DC, USA
• Dan Ollendorf, PhD, Center for the Education of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA
• Charles Phelps, PhD, University of Rochester, Rochester, NY, USA
• Lowell Schnipper, MD,  Beth Israel Deaconess Medical Center
• Suzanne Schrandt, JD, Arthritis Foundation, Washington, DC, USA
• Joshua Seidman, PhD, MHS, Avalere, Washington DC, USA
• Liz Spurgin, MBA, Medical Device Innovation Consortium, Washington, DC, USA
• Adrian Towse, MA, Office of Health Economics, London, UK

*Please revisit for updates to the growing list of speakers.